Nakhjavani Manouchehr, Khalilzadeh Omid, Khajeali Leila, Esteghamati Alireza, Morteza Afsaneh, Jamali Arsia, Dadkhahipour Sheida
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran.
Lipids. 2010 Apr;45(4):321-7. doi: 10.1007/s11745-010-3401-8. Epub 2010 Mar 12.
Oxidized low-density lipoprotein (ox-LDL) plays a key role in the progression of atherosclerosis and diabetes complications. The aim of this study was first, to evaluate the association between ox-LDL and diabetes duration, and second, to examine serum level of ox-LDL in patients with prolonged diabetes and a desirable LDL-cholesterol level. A total of 36 type-2 diabetic patients with a diabetes duration of more than 5 years, 36 newly diagnosed diabetic patients, and 36 age-, sex- and BMI-matched healthy participants were recruited. Healthy participants and newly diagnosed patients were not receiving any treatment. All patients with prolonged diabetes had desirable LDL-cholesterol levels (<100 mg/dL), according to the adult treatment panel-III guidelines. While LDL-cholesterol was significantly lower in patients with diabetes duration >5 years, in comparison to newly diagnosed patients (P < 0.01), ox-LDL was significantly higher in patients with prolonged diabetes (P < 0.001). The ox-LDL-to-LDL ratio was dramatically higher in patients with diabetes duration >5 years in comparison to newly diagnosed patients and healthy participants (P < 0.001). Ox-LDL was significantly associated with diabetes duration (r = 0.519, P = 0.001). In multivariate analysis, this association remained significant (beta = 0.501, P = 0.003) after adjustment for potential confounders. In conclusion, this study showed that the serum ox-LDL level increases with the length of diabetes, even though the patients' LDL-cholesterol level is maintained at a desirable level. Our findings highlight that possibly more attention should be focused on markers of oxidative stress in the management of lipids in diabetic patients.
氧化型低密度脂蛋白(ox-LDL)在动脉粥样硬化和糖尿病并发症的进展中起关键作用。本研究的目的,一是评估ox-LDL与糖尿病病程之间的关联,二是检测糖尿病病程较长且低密度脂蛋白胆固醇(LDL-C)水平达标的患者的血清ox-LDL水平。共招募了36例糖尿病病程超过5年的2型糖尿病患者、36例新诊断的糖尿病患者以及36例年龄、性别和体重指数(BMI)相匹配的健康参与者。健康参与者和新诊断的患者未接受任何治疗。根据成人治疗小组III指南,所有糖尿病病程较长的患者的LDL-C水平均达标(<100mg/dL)。虽然糖尿病病程>5年的患者的LDL-C显著低于新诊断的患者(P<0.01),但糖尿病病程较长的患者的ox-LDL显著更高(P<0.001)。与新诊断的患者和健康参与者相比,糖尿病病程>5年的患者的ox-LDL与LDL的比值显著更高(P<0.001)。ox-LDL与糖尿病病程显著相关(r=0.519,P=0.001)。在多变量分析中,在对潜在混杂因素进行校正后,这种关联仍然显著(β=0.501,P=0.003)。总之,本研究表明,即使患者的LDL-C水平维持在达标水平,血清ox-LDL水平仍会随着糖尿病病程的延长而升高。我们的研究结果强调,在糖尿病患者的血脂管理中,可能应更多地关注氧化应激标志物。